Drugdiscovery >> Clinical Trials >> News
2943
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III - drugdiscovery.com
Interferon-free hepatitis coctail of AbbVie enters Phase III - drugdiscovery.com


The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon.
Read More >>


Tags: interferon, hepatitis C, clinical trial, Phase III - February 6, 2014
Related Articles
6426
Views
Sofosbuvir effective in Phase II clinical trial for  hepatitis C Sofosbuvir effective in Phase II clinical trial for hepatitis C
Gilead's experimental drug sofosbuvir in combination with ribavirin showed to be effective and safe interferon-free therapy for even some of the toughest hepatitis C cases. Read More >>

Tags: sofosbuvir, hepatitis C, interferon-free therapy, ribavirin, clinical trial, Gilead

8256
Views
Glioblastoma multiforme vaccine successful in Phase 2 Glioblastoma multiforme vaccine successful in Phase 2
Agenus’ Prophage Series G-100 (HSPPC-96), used in combination with the current standard of care in patients with newly diagnosed glioblastoma multiforme, showed significant improvement in progressio Read More >>

Tags: glioblastoma multiiforme, GBM, vaccine, clinical trial, Ageon, HSPPC-96,progression free survival

5356
Views
New Alzheimer drug enters Phase 3 program New Alzheimer drug enters Phase 3 program
Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different Read More >>

Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial

7067
Views
 Melflufen enters Phase II study in the treatment of multiple myeloma patients Melflufen enters Phase II study in the treatment of multiple myeloma patients
Melflufen, also known as J1, will be used in combination with dexamethasone for late stage, relapsing or relapsing/refractory patients with multiple myeloma. The aim of this phase study is to determi Read More >>

Tags: melflufen, J1, multiple myeloma, late stage, clinical trial

5240
Views
Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial
According to the results of Phase 2 clnical trial, Humira induced a significant response rate, compared to placebo, in adult patients with moderate-to-severe hidradenitis suppurativa (HS). The drug Read More >>

Tags: Humira, AbbVie, hidradenitis suppurativa, clinical trial

4661
Views
Ovarian cancer drug demcizumab enters Phase 2 Ovarian cancer drug demcizumab enters Phase 2
OncoMed Pharmaceuticals’ stem cell product candidate, demcizumab (OMP-21M18) has entered Phase 1b/2 clinical trial and will be tested in combination with paclitaxel in patients with platinum-resista Read More >>

Tags: OncoMed, oncomed, demcizumab, ovarian cancer, fallopian tube cancer, primary peritoneal cancer

6399
Views
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial
The experimental vaccine consists of a disk-shaped, biodegradable sponge which contains growth factors and components of each patient's tumors aiming to recruit and reprogram a patient’s own immune Read More >>

Tags: melanoma, cancer, clinical trial, skin, implant, implantable, vaccine

7145
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

3441
Views
Phase-III trial of new sarcoma drug Phase-III trial of new sarcoma drug
620 patients were enrolled to the Phase-III trial of TH-302. The trial is led by Threshold Pharmaceuticals. The new drug might open a new chapter in the history of advanced soft-tissue sarcoma. Read More >>

Tags: soft tissue sarcoma, phase-III trial, soft tissue

1552
Views
Amarantus has new drug in Phase II trial Amarantus has new drug in Phase II trial
Amarantus gains rights to Eltoprazine worldwide, excluding Asian territories. Amarantus expects to initiate a Phase 2b clinical trial for the treatment of Levadopa-Induced Dyskinesia associated with P Read More >>

Tags: amarantus, Levadopa, Dykinesia

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013